Alcon Aktsia

Alcon Goodwill/vara

Goodwilli ja koguvara suhe ettevõttest Alcon (ALC.SW) seisuga 18. aug 2026 on 29,33 %. Eelmisel aastal oli Goodwilli ja koguvara suhe 29,48 % — muutus −0,50% (madalam).

Goodwill/vara

29,33 %

YoY

−0,50%

Viimati uuendatud:

Goodwilli ja koguvara suhe ettevõttest Alcon on 2026 29,33 % . Goodwilli ja koguvara suhe ettevõttest Alcon oli 2025 29,48 % . See väheneb −0,50% madalam võrreldes eelmise aastaga.
Access this data via the Eulerpool API

Alcon Aktsiate analüüs

Mida Alcon teeb? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon on üks populaarsemaid ettevõtteid Eulpoolist.

Sageli esitatud küsimused Alcon aktsia kohta

Alcon Goodwilli ja koguvara suhe on 2026. aastal 29,33 %.

Goodwilli ja koguvara suhe ettevõttest Alcon muutus 29,48 % -st 29,33 % -ks, mis vastab −0,50% muutusele. Väärtus on madalam kui eelmisel aastal.

Eulpoolist leiate Goodwilli ja koguvara suhe Alcon täieliku ajaloolise arengu alates 2006. aastast – koos aastate väärtustega, graafikutega ja üksikasjalike analüüsidega.

Goodwill/vara suhe näitab, kui suur osa koguvara koosneb aktsiatega seotud goodwillist. Kõrged suhted võivad näidata halvenemisriski.

Goodwilli ja koguvara suhe on investorite jaoks määrav tegur. Selle näitaja muutused võivad signaliseerida põhialuste paranemist või halvenemist, mõjutades otseselt aktsia hinda. Eulpoolis saate Goodwilli ja koguvara suhe Alcon ajaloolist arengut ja reaalajas andmeid jälgida.

Access this data via the Eulerpool API

Bilanss — Alcon

Kõik finantsnäitajad — Alcon